logo

For the Inventor, By the Inventor

Cupertino, CA, United States of America

Satyanarayana Medicherla

This inventor holds 12 USPTO granted patents and 2 published patent applications. Top assignees: Calyx Therapeutics, Inc., Theracos, Inc.. Active years: 2000-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satyanarayana Medicherla. Retrieved from https://idiyas.com/inventor/satyanarayana-medicherla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 58.3

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 70(Granted Patents)


Location History:

  • Sunnyvale, CA (US) (2000 - 2005)
  • Cupertino, CA (US) (2003 - 2010)

Company Filing History:

goldMedal7 out of 10 
 
Calyx Therapeutics, Inc.
 patents
silverMedal5 out of 25 
 
Theracos, Inc.
 patents

Years Active: 2000-2010

Loading Chart...
12 patents (USPTO):Explore Patents
1. 7718682 - Heterocyclic analogs of diphenylethylene compounds (2010-05-18),
2. 7202366 - Heterocyclic analogs of diphenylethylene compounds (2007-04-10),
3. 7105552 - Heterocyclic analogs of diphenylethylene compounds (2006-09-12),
4. 6855732 - Compounds to treat diabetes and associated conditions (2005-02-15),
5. 6852695 - Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes (2005-02-08),
6. 6624197 - Diphenylethylene compounds (2003-09-23),
7. 6525093 - Compounds to treat diabetes and associated conditions (2003-02-25),
8. 6448450 - 1-(3,5-dimethoxyphenyl)-2-(4-hydroxyphenyl)-ethylene for diabetes treatment (2002-09-10),
9. 6391854 - Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes (2002-05-21),
10. 6331633 - Heterocyclic analogs of diphenylethylene compounds (2001-12-18),
11. 6245814 - Diphenylethylene compounds (2001-06-12),
12. 6127338 - Orally active fraction of momordica charantia, active peptides thereof, (2000-10-03),

Title: Innovations of Satyanarayana Medicherla

Introduction

Satyanarayana Medicherla is a prominent inventor based in Cupertino, CA, known for his significant contributions to the field of medicinal chemistry. He holds a total of 12 patents, showcasing his innovative approach to developing compounds that address critical health issues.

Latest Patents

Among his latest patents are novel diphenylethylene compounds and derivatives containing thiazolidinedione or oxazolidinedione moieties. These compounds have been shown to effectively lower blood glucose levels, serum insulin, triglyceride, and free fatty acid levels in animal models of Type II diabetes. Unlike previously reported thiazolidinedione compounds that lower leptin levels, Medicherla's compounds increase leptin levels and exhibit no known liver toxicity. They are disclosed as useful for treating a variety of conditions, including inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer, and multiple sclerosis.

Career Highlights

Throughout his career, Satyanarayana Medicherla has worked with notable companies such as Calyx Therapeutics, Inc. and Theracos, Inc. His work has significantly impacted the development of therapeutic agents aimed at improving health outcomes.

Collaborations

Some of his notable coworkers include Bishwajit Nag and Debendranath Dey, who have collaborated with him on various projects.

Conclusion

Satyanarayana Medicherla's innovative work in developing therapeutic compounds has made a substantial impact in the field of medicine. His contributions continue to pave the way for advancements in treatments for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…